ABSTRACT
INTRODUCTION
Mammalian cell lines and yeast are two commonly used host systems for the expression of recombinant gene products (9) . Yeast systems are easy to handle and usually express high levels of proteins, while mammalian expression systems may produce more native biological materials. However, both systems have their limitations. For example, mammalian proteins produced in yeast will have different glycosylation patterns from their native form. Conversely, establishing a mammalian cell line for protein production is time-consuming, and the yield of product is relatively low in comparison with yeast. Choosing a proper system for protein expression has been an empirical matter.
The Pichia pastoris yeast strain is one of those most commonly used in protein expression, due to its high productivity and convenient media selection. To achieve protein expression in mammalian and yeast systems such as P. pastoris , two separate expression plasmids must be constructed. Therefore, it would be desirable to design a shuttle expression vector that would allow exploration of protein expression in both systems quickly. We have developed such a plasmid vector and succeeded in using this vector to express β -galactosidase ( β -gal) in several mammalian cell lines and in the yeast strain, P. pastoris .
MATERIALS AND METHODS

Plasmid Construction
The yeast P. pastorisexpression vector pHIL-D2 was obtained from Invitrogen (Catalog No. K1710-01; Carlsbad, CA, USA). A fragment containing the mammalian promoter SR α (from the DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA, USA; and Reference 10) and the human β -globin 5 ′ splice site was cloned into the Nde I site of pHIL-D2 blunt-ended by Klenow enzyme. Another fragment containing an immunoglobulin 3 ′ splice site, a polylinker and a simian virus 40 (SV40) late polyadenylation signal was then inserted into the Eco RI site of the previous construct blunt-ended with Klenow enzyme. The resulting vector was named pPM-2. To insert a target gene, an Sma I-Dra I fragment from pSVβ (Catalog No. 6178-1; CLONTECH Laboratories, Palo Alto, CA, USA) containing a β -gal cDNA was cloned into the Sma I site of pPM-2 (pPM-2-β gal). The above constructs were mapped with multiple restriction digestions and confirmed by DNA sequencing analysis. To generate riboprobes used in the subsequent RNase protection assay, plasmid R-6 was constructed by inserting a Pvu I-Hin dIII fragment of pPM-2-β gal into the Eco RV site of a pBluescript ® SK II vector (Stratagene, La Jolla, CA, USA). The insert spans across the 3 ′ splice site of pPM-2-β gal.
Yeast and Mammalian Cell Culture
The yeast P. pastorisstrain GS115 (K1710-01) was obtained from Invitrogen. Its propagation, competent cell preparation and selection procedures followed the manufacturer's recommendations. Before electroporation into competent GS115 cells, the pPM-2-β gal was digested with Not I to release the yeast expression cassette. Mammalian cells were maintained following standard tissue-culture techniques. Culture media for individual cell lines followed ATCC (Rockville, MD, USA) recommendations. Supercoiled pPM-2-β gal (10 µ g) was transfected, using the calcium phosphate precipitation protocol (8), into cells on 10-cm tissue culture dishes. 
Sho r t Technical Repo r t s
Assays for β β -gal Expression
For the yeast P. pastoris , selected clones were scaled up for production. Each was sampled at different time points, as indicated in Figure 2 . Cell lysates were prepared according to the manufacturer's protocols. For mammalian cells, total cell lysates were prepared 48 h after transfection. Amounts of β -gal produced by yeast and different mammalian cell lines were quantitated by an enzyme-linked immunosorbent assay (ELISA) kit (Catalog No. 1 539 426; Boehringer Mannheim, Indianapolis, IN, USA). The enzymatic activity was measured with the β -Galactosidase Enzyme Assay System (Promega, Madison, WI, USA). Protein concentrations were measured by BCA™Protein Assay (Pierce Chemical, Rockford, IL, USA).
RNA Isolation and RNase Protection Assay
Poly(A+) RNA samples were isolated from CHO-K1 cells 48 h after transfection with pPM-2-β gal (Oligotex ™ mRNA Isolation Kit; Qiagen, Chatsworth, CA, USA). R-6 was linearized by Xba I digestion and in vitro-transcribed with T7 DNA polymerase. Approximately 1 µ g of poly(A+) RNA sample was used for the RNase protection assay, supplemented with 20 µ g of total RNA from untransfected CHO-K1 cells (Catalog No. 1410; Ambion, Austin, TX, USA). Digested samples were resolved on a 6% denaturing polyacrylamide gel.
RESULTS
Vector Design
Splicing of mRNA requires a pair of splice sites on the nascent mRNA precursor. These sites are cleaved and rejoined at adjacent exons to remove the non-coding intron from the mature mRNA (5,7). This process is required for the export, stability and eventually the accumulation of most protein-encoding mRNA species in the cytoplasm of mammalian cells (1). In our vector design, the yeast promoter P5 ′ AOXwas placed between the 5 ′ and 3 ′ splice sites so that it would be removed as part of the intron during splicing when transfected into mammalian cells (Figure 1 ). The removal of yeast promoter allows efficient expression from the transcription unit driven by the SR αpromoter. Moreover, in P. pastoris yeast, both the mammalian promoter and the 5 ′ splice site are removed by Not I digestion before electroporation. The same cDNA fragment downstream of the 3 ′ splice site can be transcribed from the 5 ′ AOX promoter. The 3 ′ -splice-site region between the polylinker and the P5 ′ AOX was engineered to remove any potential translation initiation codons (ATG). In addition, the transcription termination (TT) element of the yeast shares no apparent homology with that of the mammalian Poly(A) signal (6) . Thus, there should be no interference between the two promoter elements and the two termination signals.
Expression of β β -gal Protein in Yeast P. pastoris
A total of five clones of P. pastoris transformed with pPM-2-β gal were expanded for assay of β -gal protein expression after His selection. Two were positive by ELISA. Both cultures were further sampled at various times in the following experiment. The amounts of β -gal produced were measured by ELISA (Figure 2 ). The β -gal enzymatic activity of these samples was confirmed in a separate experiment (data not shown). Our data indicate that both clones have a similar level of β -gal expression and are stable for at least three days.
Expression of β β -gal in Mammalian Cell Lines
Six mammalian cell lines were tested for β -gal expression from pPM-2-β gal. All except for HeLa S3 expressed β -gal. The β -gal production was 268BioTechniques
Vol. 24, No. 2 (1998) Figure 2 . β β -gal protein expression in yeast P. pastoris . The GS115 strain of yeast P. pastoris was transformed with pPM-2-β gal. After His selection, two clones expressing β -gal were identified and maintained for 3 days under continuous methanol induction. Yeast samples were collected at various time points, as indicated. Cell lysates were prepared to assay for β -gal production by ELISA. The amounts of β -gal were normalized against total cellular protein. These yeast lysates were found to be enzymatically active in a separate experiment (data not shown). measured simultaneously by both ELISA and its enzymatic activities (Figure 3) . Among the cell lines tested, the highest level of β -gal expression was seen with COS-7 cells, presumably due to the presence of an SV40 promoter in the plasmids and a large T antigen expressed in COS-7 cells.
Removal of the 5 ′ ′ AOX Promoter in CHO-K1 Cells
To verify the efficiency and accuracy of removal of the 5 ′ AOXpromoter by RNA splicing, an RNase protection assay with a riboprobe (R-6) spanning the 3 ′ -splice-site region was performed ( Figure 4A ). In particular, a 32 P-labeled riboprobe was annealed to mRNA sample isolated from CHI-K1 cells transfected with pPM-2-β gal. Following RNase digestion, the sample was resolved on a denaturing polyacrylamide gel. Results showed no detectable level of unspliced mRNA from the poly(A+) RNA sample ( Figure 4B ). This indicates that the intron is efficiently removed from the mRNA molecules. The excision occurs precisely at the 3 ′ splice site indicated (Figure 4 ).
DISCUSSION
The number of genes identified has grown rapidly in recent years. Many of the gene products need to be expressed as either wild-type or mutated forms in several biological systems, to study their structure and function. To meet this challenge, we have constructed a dual mammalian/yeast expression vector that is capable of expressing recombinant proteins in both host systems. The organization of this vector allows a yeast ( P. pastoris ) transcription unit to function independently from an overlapping mammalian expression cassette. In mammalian cells, the transcript derived from the SR αpromoter is properly processed and accumulated in the cytoplasm for translation. Our data have shown that splicing efficiently removed yeast promoter elements from poly(A+) mRNA (Figure 4 and Reference 3). In yeast P. pastoris , gene expression is controlled by the yeast 5 ′ AOXpromoter. The transforming plasmid is linearized at Not I sites, thereby disrupting the mammalian expression cassette. The mammalian polyadenylation site will be ignored, since the SV40 poly(A) signal shares no homology with the TT sequence of the yeast.
It is foreseeable that more shuttle expression vectors can be built based on a similar design. For example, a combination of the T7 promoter and a mammalian promoter can achieve protein expression in both E. coli and mammalian cell lines. Furthermore, a selection marker can also be incorporated into the vector to allow the establishment of permanent clones expressing desired targets in mammalian cells (2, 4) .
INTRODUCTION
Recent studies have shown the possibility of analyzing RNA extracted from fixed and paraffin-embedded tissues (5, 14, 16) . A specific RNA analysis in embedded tissues facilitates the utilization of human pathological tissues. In fact, all bi-optical or surgical tissues are routinely fixed and paraffinembedded and conserved for many years.
Some of the methods proposed (14) for the RNA extraction utilize single 6-8-µ m histological sections from paraffin blocks. The RNA is first transcribed into cDNA and subsequently amplified with the polymerase chain reaction (PCR) technology. Methods to quantify RNA extracted from fresh tissues after PCR amplification have already been proposed (2, 7, 10) . However, the quantitation of RNA from paraffin-embedded tissues presents specific problems that cannot be resolved with a quantitative competitive analysis because of the variable level of RNA degradation in the samples. We describe a relative quantitative analysis of specific RNA sequences from fixed and paraffin-embedded human tissues, comparing the membrane hybridization (MH) and capillary electrophoresis (CE) methods.
MATERIALS AND METHODS
Human tissues from surgical or autopsy origin were fixed with 10% buffered formalin and then paraffin-
